LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 61 filers reported holding LEAP THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,074 | -24.4% | 6,100 | 0.0% | 0.00% | – |
| Q4 2022 | $2,745 | -45.1% | 6,100 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 6,100 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -36.4% | 6,100 | 0.0% | 0.00% | – |
| Q1 2022 | $11,000 | -45.0% | 6,100 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | -16.7% | 6,100 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | +140.0% | 6,100 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 6,100 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | -14.3% | 6,100 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +16.7% | 6,100 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | -7.7% | 6,100 | 0.0% | 0.00% | – |
| Q2 2020 | $13,000 | +30.0% | 6,100 | 0.0% | 0.00% | – |
| Q1 2020 | $10,000 | +42.9% | 6,100 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 6,100 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | -36.4% | 6,100 | 0.0% | 0.00% | – |
| Q2 2019 | $11,000 | 0.0% | 6,100 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | -8.3% | 6,100 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -75.0% | 6,100 | 0.0% | 0.00% | – |
| Q3 2018 | $48,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 2,664,400 | $2,345,000 | 2.45% |
| Key Client Fiduciary Advisors, LLC | 1,120,943 | $986,000 | 0.89% |
| Knott David M Jr | 900,000 | $792,000 | 0.33% |
| ACT CAPITAL MANAGEMENT, LLC | 265,000 | $233,000 | 0.32% |
| Perceptive Advisors | 7,472,148 | $6,575,000 | 0.19% |
| Tri Locum Partners LP | 711,798 | $626,000 | 0.17% |
| 683 Capital Management, LLC | 2,265,000 | $1,993,000 | 0.15% |
| Artal Group S.A. | 4,000,000 | $3,520,000 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 1,250,000 | $1,100,000 | 0.14% |
| HealthCor Management, L.P. | 1,066,689 | $939,000 | 0.12% |